Parallel Advisors, LLC Nektar Therapeutics Transaction History

Parallel Advisors, LLC

$3.87 Billion
Q2 2024

A detailed history of Parallel Advisors, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Parallel Advisors, LLC holds 15,820 shares of NKTR stock, worth $20,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,820

Previous 15,820 -0.0%

Holding current value

$20,566

Previous $14,000 35.71%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$0.64 - $3.15 $635 - $3,127	-993 Reduced 5.91%	15,820 $11,000
Q4 2022 Feb 03, 2023	SELL	$2.03 - $4.28 $2,239 - $4,720	-1,103 Reduced 6.16%	16,813 $37,000
Q3 2022 Nov 10, 2022	BUY	$3.04 - $5.14 $723 - $1,223	238 Added 1.35%	17,916 $57,000
Q2 2022 Aug 01, 2022	BUY	$3.17 - $6.17 $2,329 - $4,534	735 Added 4.34%	17,678 $67,000
Q1 2022 Apr 28, 2022	SELL	$4.16 - $13.72 $2,412 - $7,957	-580 Reduced 3.31%	16,943 $94,000
Q4 2021 Jan 20, 2022	BUY	$10.83 - $18.41 $3,790 - $6,443	350 Added 2.04%	17,523 $237,000
Q3 2021 Nov 02, 2021	BUY	$13.07 - $18.84 $4,927 - $7,102	377 Added 2.24%	17,173 $308,000
Q2 2021 Aug 06, 2021	SELL	$16.52 - $20.4 $726 - $897	-44 Reduced 0.26%	16,796 $288,000
Q1 2021 Apr 23, 2021	BUY	$16.56 - $25.46 $960 - $1,476	58 Added 0.35%	16,840 $337,000
Q4 2020 Feb 02, 2021	SELL	$15.77 - $19.03 $6,386 - $7,707	-405 Reduced 2.36%	16,782 $285,000
Q3 2020 Oct 27, 2020	BUY	$16.59 - $24.79 $20,438 - $30,541	1,232 Added 7.72%	17,187 $285,000
Q2 2020 Jul 16, 2020	SELL	$16.86 - $23.44 $758 - $1,054	-45 Reduced 0.28%	15,955 $369,000
Q1 2020 Apr 27, 2020	BUY	$14.47 - $27.96 $3,834 - $7,409	265 Added 1.68%	16,000 $285,000
Q4 2019 Jan 30, 2020	BUY	$15.87 - $23.12 $1,206 - $1,757	76 Added 0.49%	15,735 $340,000
Q2 2019 Aug 05, 2019	BUY	$31.0 - $36.3 $1,829 - $2,141	59 Added 0.38%	15,659 $557,000
Q3 2018 Nov 01, 2018	SELL	$46.46 - $68.49 $1,626 - $2,397	-35 Reduced 0.22%	15,600 $951,000
Q2 2018 Jul 30, 2018	BUY	$46.25 - $104.45 $3,931 - $8,878	85 Added 0.55%	15,635 $763,000
Q1 2018 May 08, 2018	BUY	$57.4 - $108.44 $892,570 - $1.69 Million	15,550 New	15,550 $1.65 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Nektar Therapeutics Transaction History